Vitros Immunodiagnostic Products Cea Calibrators, Vitros Immunodiagnostic Products Cea Reagent Pack
System, Test, Carcinoembryonic Antigen. 510(k) K990943, from Ortho-Clinical Diagnostics, Inc. (Rochester, NY). Product code DHX, class 2.
As of Nov 20, 2026, K990943 is an FDA 510(k) held by Ortho-Clinical Diagnostics, Inc., substantially equivalent on Jun 1, 1999 after 71 days, with no recalls tied to it in FDA's recall database.
- Review time: 71 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Vitros® CEA is an in vitro assay intended for the quantitative measurement of carcinoembryonic antigen (CEA) in human serum and plasma (EDTA or heparin) to aid in the prognosis and management of cancer patients in whom changing concentrations of CEA are observed.
- P830066P830066
- Vitros Immunodiagnostic Products Cea Reagent Pack/Calibrator/Range VerifiersK041322 · Ortho-Clinical Diagnostics, Inc. · Jun 17, 2004
- Access CEAK223921 · Beckman Coulter, Inc. · Sep 22, 2023
- VITROS Immunodiagnostic Products CEA Reagent PackK231517 · Ortho Clinical Diagnostics · Aug 23, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 22, 1999
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files